---
title: LOTTE Biologics vs Merck KGaA
slug_a: lotte-biologics
slug_b: merck-kgaa
site: cdmo
review_signal_gate: closed
canonical_path: /compare/lotte-biologics/merck-kgaa
---

# LOTTE Biologics vs Merck KGaA

Side-by-side profile data from each company listing on this directory.

## LOTTE Biologics

- Profile: [/companies/lotte-biologics](/companies/lotte-biologics)

LOTTE Biologics — LOTTE Biologics offers biologics CDMO services spanning process and analytical development, antibody manufacturing from clinical to commercial GMP, and bioconjugate manufacturing. Its operations are based at campuses in Syracuse, New York and Songdo, Incheon.

Services: 7. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Bioconjugation Services
- Process Development
- CMC Analytical Development
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)

## Merck KGaA

- Profile: [/companies/merck-kgaa](/companies/merck-kgaa)

Merck KGaA — Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.

Services: 0. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in locations (1).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.